RxDoctor Payments Data

Justin Croft, PA

Physician Assistant · Aiken, SCNPI 1770835522

Payments from drug & device makers

$5,996in general payments, 2019–2025

Across 376 payments — averaging $15.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$736
  • AstraZeneca$610
  • Novo Nordisk$587
  • Abbott$442
  • Pfizer$277
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,989100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,996 in reported general payments places this provider in the 90th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$100,093
Medicare patients
341
Services billed
1,840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide62$64,544
OzempicSemaglutide64$64,320
JardianceEmpagliflozin30$38,594
JanuviaSitagliptin Phosphate28$27,026
EliquisApixaban19$21,916
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$15,115
Tresiba Flextouch U-200Insulin Degludec21$13,637
Tresiba Flextouch U-100Insulin Degludec20$11,531
Breo ElliptaFluticasone/Vilanterol18$6,625
Humalog Kwikpen U-200Insulin Lispro12$4,737
Duloxetine Hcl33$2,897
Candesartan Cilexetil40$2,142
Ezetimibe27$1,954
Albuterol Sulfate HfaAlbuterol Sulfate56$1,602
Atorvastatin Calcium193$1,311

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$736$64,54462 claims
Novo NordiskOzempic$587$64,32064 claims
Boehringer IngelheimJardiance$143$38,59430 claims
MerckJanuvia$49$27,02628 claims
PfizerEliquis$277$21,91619 claims
AstraZenecaBreztri Aerosphere$610$15,11521 claims
GSKBreo Ellipta$59$6,62518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Aiken

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →